- The Central Drugs Standard Control Organisation has approved Siemens Healthineers to manufacture RT-PCR testing kits for detecting Mpox.
- The RT-PCR kits provide test results in 40 minutes, significantly faster than traditional methods, reducing turnaround time for quicker responses.
- The IMDX Monkeypox Detection RT-PCR Assay targets two distinct regions in the viral genome, covering both clade I and clade II variants.
- It is platform-agnostic, integrating seamlessly into existing lab workflows without requiring new instruments, thus leveraging existing COVID testing infrastructure.
- The assay, clinically validated by the Indian Council of Medical Research, National Institute of Virology, Pune, has 100% sensitivity and specificity.
Dig Deeper: Read about the Central Drugs Standard Control Organisation (CDSCO)